(Q46798604)

English

Multicenter randomized, double-blind, placebo-controlled, clinical trial of dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris

scientific article published in January 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18209165

Multicenter randomized, double-blind, placebo-controlled, clinical trial of dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18209165

1 reference

based on heuristic

inferred from title

multicenter clinical trial

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Pemphigus vulgaris

object named as

pemphigus vulgaris

1 reference

based on heuristic

inferred from title

author name string

Victoria P Werth

1

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18209165

David Fivenson

2

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18209165

Amit G Pandya

3

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18209165

Diana Chen

4

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18209165

M Joyce Rico

5

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18209165

Joerg Albrecht

6

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18209165

David Jacobus

7

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18209165

publication date

1 January 2008

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18209165

Archives of Dermatology

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18209165

144

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18209165

1

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18209165

25-32

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18209165

Dermatitis herpetiformis with acantholysis or pemphigus with response to sulfonamides: report of two cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/18209165

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant Therapy of Pemphigus

1 reference

https://pubmed.ncbi.nlm.nih.gov/18209165

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dapsone in the Treatment of Pemphigus Vulgaris

1 reference

https://pubmed.ncbi.nlm.nih.gov/18209165

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

When and how to use sulfones in bullous diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/18209165

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of pemphigus vulgaris and pemphigus foliaceus with mycophenolate mofetil

1 reference

https://pubmed.ncbi.nlm.nih.gov/18209165

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differences and similarities among expert opinions on the diagnosis and treatment of pemphigus vulgaris

1 reference

https://pubmed.ncbi.nlm.nih.gov/18209165

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mycophenolate is effective in the treatment of pemphigus vulgaris

1 reference

https://pubmed.ncbi.nlm.nih.gov/18209165

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An evaluation of the usefulness of mycophenolate mofetil in pemphigus

1 reference

https://pubmed.ncbi.nlm.nih.gov/18209165

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus

1 reference

https://pubmed.ncbi.nlm.nih.gov/18209165

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of pemphigus: a local experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/18209165

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized controlled trial of adjuvant oral dexamethasone pulse therapy in pemphigus vulgaris: PEMPULS trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18209165

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pemphigus controlled by dapsone

1 reference

https://pubmed.ncbi.nlm.nih.gov/18209165

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pemphigus vegetans: its relationship to eosinophilic spongiosis and favorable response to dapsone

1 reference

https://pubmed.ncbi.nlm.nih.gov/18209165

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of pemphigus vulgaris by azathioprine and low doses of prednisone (Lever scheme)

1 reference

https://pubmed.ncbi.nlm.nih.gov/18209165

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pemphigus controlled by sulphapyridine

1 reference

https://pubmed.ncbi.nlm.nih.gov/18209165

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Azathioprine in the treatment of pemphigus vulgaris. A long-term follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/18209165

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of pemphigus

1 reference

https://pubmed.ncbi.nlm.nih.gov/18209165

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dapsone—Other Indications

1 reference

https://pubmed.ncbi.nlm.nih.gov/18209165

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18209165

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of pemphigus with corticosteroids and cyclophosphamide

1 reference

https://pubmed.ncbi.nlm.nih.gov/18209165

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of oral pemphigus vulgaris

1 reference

https://pubmed.ncbi.nlm.nih.gov/18209165

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful use of cyclophosphamide and prednisone for initial treatment of pemphigus vulgaris

1 reference

https://pubmed.ncbi.nlm.nih.gov/18209165

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1001/ARCHDERM.144.1.25

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18209165

PMC publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18209165

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46798604&oldid=2132730101"